ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 Post author:Sam Post published:September 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Creative Bioarray Release: New Products of FISH Have Been Released In Company January 19, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Hygieia Completes Acquisition Of Global Food Safety Diagnostics Business From DuPont February 28, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Hygieia Completes Acquisition Of Global Food Safety Diagnostics Business From DuPont February 28, 2017